Mon Sep 23 22:28:50 UTC 2024: ## Hims & Hers CEO Sells Shares Amidst Mixed Analyst Opinions

**New York, NY -** Hims & Hers Health, Inc. (NYSE: HIMS) CEO Andrew Dudum sold 45,767 shares of the company’s stock on September 20th, totaling $747,375.11. This transaction follows a period of mixed analyst opinions on the telehealth platform provider.

While some analysts, like Deutsche Bank and Truist Financial, have upped their price targets on Hims & Hers, others, such as Imperial Capital, have downgraded their ratings. Overall, the stock currently holds a “Moderate Buy” rating with a consensus price target of $19.86, according to MarketBeat.

Despite the insider sale, large institutional investors remain confident in the company. Several funds, including Victory Capital Management Inc. and Quantbot Technologies LP, have increased their holdings in Hims & Hers during recent quarters.

Hims & Hers continues to offer a range of health and wellness products and services through its telehealth platform, expanding its reach both domestically and internationally. The company’s market cap currently stands at $3.52 billion.

**HIMS stock closed at $16.41 on Monday, up $0.11 from the previous day. The stock’s 50-day moving average is $17.35, and its 200-day moving average is $17.09.**

**Investors are closely monitoring the company’s performance as it navigates a competitive telehealth market.**

Read More